Lee Jong Min, Kang Jeonghyun
Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.
Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
J Inflamm Res. 2025 Jul 8;18:8935-8944. doi: 10.2147/JIR.S529218. eCollection 2025.
PURPOSE: While preoperative prognostic nutritional index (PNI) is a well-established prognostic marker in colorectal cancer (CRC), and postoperative PNI has gained attention, their combined prognostic value remains largely unexplored. PATIENTS AND METHODS: We analyzed patients who underwent curative surgery for stage I-III CRC between March 2004 and February 2014. The pre- and postoperative PNI, measured within 1 month before and 3-8 weeks after surgery, were combined to create "change-PNI" The Cox proportional hazards model was used to assess the prognostic significance, and the C-index was compared across values. RESULTS: The optimal pre- and postoperative PNI cutoff values predicting 5-year overall survival (OS) were 48.05 and 43.65, respectively. The patients were categorized into four groups based on their pre- and postoperative values: pre-low + post-low (G1), pre-low + post-high (G2), pre-high + post-low (G3), and pre-high + post-high (G4). A multivariable Cox proportional hazards model demonstrated that patients in G2, G3, and G4 had significantly lower mortality risks than those in G1 (HR [95% CI] vs G1: G2, 0.341 [0.186-0.625]; G3, 0.457 [0.222-0.941]; G4, 0.222 [0.123-0.401]). The C-index of change-PNI (0.671, 95% CI 0.617-0.720) was superior to that of preoperative PNI (0.609, 95% CI 0.563-0.654) (bootstrap mean difference: 0.062, 95% CI 0.029-0.099) and postoperative PNI (0.622, 95% CI 0.581-0.664) (bootstrap mean difference: 0.049, 95% CI 0.014-0.085). CONCLUSION: Change-PNI serves as a more effective independent immuno-nutritional marker than pre- or postoperative PNI in predicting OS in patients undergoing surgery for non-metastatic colorectal cancer.
目的:术前预后营养指数(PNI)是结直肠癌(CRC)中一个已确立的预后标志物,术后PNI也受到了关注,但其联合预后价值在很大程度上仍未得到探索。 患者与方法:我们分析了2004年3月至2014年2月期间接受I - III期CRC根治性手术的患者。术前1个月内及术后3 - 8周测量的术前和术后PNI被合并以创建“变化-PNI”。采用Cox比例风险模型评估预后意义,并比较不同值的C指数。 结果:预测5年总生存期(OS)的最佳术前和术后PNI临界值分别为48.05和43.65。根据患者术前和术后的值将其分为四组:术前低 + 术后低(G1)、术前低 + 术后高(G2)、术前高 + 术后低(G3)和术前高 + 术后高(G4)。多变量Cox比例风险模型表明,G2、G3和G4组患者的死亡风险显著低于G l组(HR [95% CI] 与G1组相比:G2组,0.341 [0.186 - 0.625];G3组,0.457 [0.222 - 0.941];G4组,0.222 [0.123 - 0.401])。变化-PNI的C指数(0.671,95% CI 0.617 - 0.720)优于术前PNI(0.609,95% CI 0.563 - 0.654)(自抽样均值差:0.062,95% CI 0.029 - 0.099)和术后PNI(0.622,95% CI 0.581 - 0.664)(自抽样均值差:0.049,95% CI 0.014 - 0.085)。 结论:在预测接受非转移性结直肠癌手术患者的OS方面,变化-PNI作为一种比术前或术后PNI更有效的独立免疫营养标志物。
Cochrane Database Syst Rev. 2022-9-26
Cochrane Database Syst Rev. 2018-2-6
Cochrane Database Syst Rev. 2012-3-14
Clin Orthop Relat Res. 2024-9-1
Clin Orthop Relat Res. 2025-6-1
Cancers (Basel). 2024-6-22
Dis Colon Rectum. 2024-5-1
Ann Coloproctol. 2022-4